The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab

Ital J Dermatol Venerol. 2023 Aug;158(4):365-367. doi: 10.23736/S2784-8671.23.07475-3. Epub 2023 Jul 11.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • COVID-19*
  • Dermatitis, Atopic* / drug therapy
  • Dermatitis, Atopic* / epidemiology
  • Humans
  • Pandemics

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized